VERU INC. Deferred Compensation Liability, Current
VERU INC. (VERU) had Deferred Compensation Liability, Current of $2.68 million as of 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredCompensationLiabilityCurrent · last filed 2024-05-08
- 2024-03-31: Deferred Compensation Liability, Current $2.68M.
- 2023-12-31: Deferred Compensation Liability, Current $2.15M.
- 2023-09-30: Deferred Compensation Liability, Current $990.61K.
- 2023-06-30: Deferred Compensation Liability, Current $3.55M.
| Period end | Deferred Compensation Liability, Current |
|---|---|
| 2024-03-31 | $2.68M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.15M 10-Q · filed 2024-04-01 |
| 2023-09-30 | $990.61K 10-Q · filed 2024-05-08 |
| 2023-06-30 | $3.55M 10-Q/A · filed 2023-11-15 |
| 2023-03-31 | $2.99M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.14M 10-Q · filed 2023-02-09 |
| 2022-09-30 | $5.99M 10-K/A · filed 2024-04-01 |
| 2022-06-30 | $4.02M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.39M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.02M 10-Q · filed 2022-02-09 |
| 2021-09-30 | $4.99M 10-K · filed 2022-12-05 |
| 2021-06-30 | $2.76M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.23M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.93M 10-Q · filed 2021-02-10 |
| 2020-09-30 | $2.27M 10-K · filed 2021-12-02 |
| 2020-06-30 | $2.20M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $1.54M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $1.34M 10-Q · filed 2020-02-12 |
| 2019-09-30 | $1.60M 10-K · filed 2020-12-10 |
| 2018-09-30 | $687.25K 10-K · filed 2019-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |